Adjuvant hormone therapy in locally advanced and localized prostate cancer: three EORTC trials

Evaluating surrogates for overall survival in the adjuvant treatment of bladder cancer with chemotherapy.

Urologic oncology·2025

Safety and preliminary activity results of the GATTO study, a phase Ib study combining the anti-TA-MUC1 antibody gatipotuzumab with the anti-EGFR tomuzotuximab in patients with refractory solid tumors.

ESMO open·2022

Maintenance therapy of patients with recurrent epithelial ovarian carcinoma with the anti-tumor-associated-mucin-1 antibody gatipotuzumab: results from a double-blind, placebo-controlled, randomized, phase II study.

ESMO open·2021

Study protocol: understanding the pathophysiologic mechanisms underlying delirium in older people undergoing hip fracture surgery.

BMC geriatrics·2021

A randomized phase II study comparing the efficacy and safety of the glyco-optimized anti-EGFR antibody tomuzotuximab against cetuximab in patients with recurrent and/or metastatic squamous cell cancer of the head and neck - the RESGEX study.

ESMO open·2021

Independent external validation using the EORTC HNCG-ROG 1219 DAHANCA trial data of NTCP models for acute oral mucositis.

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology·2021

Proton therapy in the clinic.

Frontiers of radiation therapy and oncology·2011

Proton therapy: clinical gains through current and future treatment programs.

Frontiers of radiation therapy and oncology·2011

Stereotactic body radiotherapy for prostate cancer: current results of a phase II trial.

Frontiers of radiation therapy and oncology·2011

Stereotactic body radiation therapy for gastrointestinal malignancies.

Frontiers of radiation therapy and oncology·2011

Stereotactic body radiation therapy for thoracic cancers: recommendations for patient selection, setup and therapy.

Frontiers of radiation therapy and oncology·2011

Stereotactic body radiation therapy: normal tissue and tumor control effects with large dose per fraction.

Frontiers of radiation therapy and oncology·2011

Combined inulin, glucomannan, and medium-chain triglyceride modulate metabolic and inflammatory responses in chemotherapy-treated colorectal cancer cells.

Journal of advanced pharmaceutical technology & research·2026

Erratum: Evaluation of the combination of chitosan hydrogel crosslinker and dental pulp stem cell-derived exosomes on osteoblast viability and differentiation.

Journal of advanced pharmaceutical technology & research·2026

Engineered Nanozymes for Colorectal Cancer Therapy: Catalytic Reprogramming of the Tumor Microenvironment.

International journal of nanomedicine·2026

Selenium-Doped Calcium Hydroxide Nanoparticles Inhibit Osteoclasts and Promote Osteogenesis for Osteoporosis Treatment.

International journal of nanomedicine·2026

Efficacy of cryotherapy for oral leukoplakia: A systematic review.

Journal of dental sciences·2026

The multifaceted impact of the COVID-19 pandemic on colorectal cancer care: a systematic review of management disruptions, stage migration, and survival outcomes.

Frontiers in oncology·2026

Related Experiment Videos

Adjuvant hormone therapy in locally advanced and localized prostate cancer: three EORTC trials

Related Concept Videos

Evaluating surrogates for overall survival in the adjuvant treatment of bladder cancer with chemotherapy.

Safety and preliminary activity results of the GATTO study, a phase Ib study combining the anti-TA-MUC1 antibody gatipotuzumab with the anti-EGFR tomuzotuximab in patients with refractory solid tumors.

Maintenance therapy of patients with recurrent epithelial ovarian carcinoma with the anti-tumor-associated-mucin-1 antibody gatipotuzumab: results from a double-blind, placebo-controlled, randomized, phase II study.

Study protocol: understanding the pathophysiologic mechanisms underlying delirium in older people undergoing hip fracture surgery.

A randomized phase II study comparing the efficacy and safety of the glyco-optimized anti-EGFR antibody tomuzotuximab against cetuximab in patients with recurrent and/or metastatic squamous cell cancer of the head and neck - the RESGEX study.

Independent external validation using the EORTC HNCG-ROG 1219 DAHANCA trial data of NTCP models for acute oral mucositis.

Proton therapy in the clinic.

Proton therapy: clinical gains through current and future treatment programs.

Stereotactic body radiotherapy for prostate cancer: current results of a phase II trial.

Stereotactic body radiation therapy for gastrointestinal malignancies.

Stereotactic body radiation therapy for thoracic cancers: recommendations for patient selection, setup and therapy.

Stereotactic body radiation therapy: normal tissue and tumor control effects with large dose per fraction.

Combined inulin, glucomannan, and medium-chain triglyceride modulate metabolic and inflammatory responses in chemotherapy-treated colorectal cancer cells.

Erratum: Evaluation of the combination of chitosan hydrogel crosslinker and dental pulp stem cell-derived exosomes on osteoblast viability and differentiation.

Engineered Nanozymes for Colorectal Cancer Therapy: Catalytic Reprogramming of the Tumor Microenvironment.

Selenium-Doped Calcium Hydroxide Nanoparticles Inhibit Osteoclasts and Promote Osteogenesis for Osteoporosis Treatment.

Efficacy of cryotherapy for oral leukoplakia: A systematic review.

The multifaceted impact of the COVID-19 pandemic on colorectal cancer care: a systematic review of management disruptions, stage migration, and survival outcomes.

Related Experiment Videos

Adjuvant hormone therapy in locally advanced and localized prostate cancer: three EORTC trials

Related Concept Videos

Related Articles